Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis
Acute Appendicitis
About this trial
This is an interventional treatment trial for Acute Appendicitis focused on measuring Acute appendicitis, Endoscopic retrograde appendicitis therapy, Endoscopic retrograde appendicography, Endoscopic therapy, Appendectomy, Antibiotic Therapy
Eligibility Criteria
Inclusion Criteria:
- patients with Alvarado scores ≥7 (with or without US/CT) diagnosed of uncomplicated acute appendicitis
- patients with Alvarado scores <7 but US/CT suggested uncomplicated acute appendicitis or could not exclude acute appendicitis.
Exclusion Criteria:
- perforated appendicitis
- periappendiceal abscess
- contraindications for colonoscopy
- allergy to contrast media or iodine
- pregnancy
- unable to cooperate or provide informed consent
Sites / Locations
- 3201 Hospital of Hanzhong
- Second Affiliated Hospital of Xi'an Jiaotong University
- First Affiliated Hospital of Xian Jiaotong University
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Active Comparator
Antibiotic therapy group
ERAT group
Appendectomy group
The patients will be treated with intravenous broad-spectrum antibiotics (Ertapenem 1g/d) for 3 days and oral antibiotics (Levofloxacin 500mg once daily and Metronidazole 500mg 3 times per day) for 7 days. If patients in the antibiotic group deteriorate during the hospital stay (suspicious perforation or any symptoms of peritonitis) patients will be operated.
The patients will receive emergent endoscopic retrograde appendicitis therapy (ERAT).
The patients will receive laparoscopic appendectomy according to standard routines.